Assessment of pain prevalence in cancer patients undergoing anticancer treatments and in cancer survivors after completion of anticancer treatments: A French nationwide cross‐sectional study DOI

Charles Ragusa,

Bruno Pereira, David Balayssac

и другие.

International Journal of Cancer, Год журнала: 2024, Номер unknown

Опубликована: Дек. 3, 2024

Abstract Pain is a common and disabling symptom of cancer its treatment. This study aimed to provide an update on the prevalence, characteristics, impact pain quality life (QoL) in patients survivors France. Data were collected using self‐assessment questionnaires as part nationwide web‐based survey conducted between January March 2023. was reported by 44.7% population ( n = 1029), including 49.2% (95% CI [44.8; 53.6]) 255/518) 40.1% [35.8; 44.5]) 205/511). Chronic more prevalent among (99.0%) than (87%), but no between‐group differences prevalence neuropathic (66.8% vs. 67.5%, respectively) or other characteristics (pain intensity, location, etc.) observed. had negative QoL both groups, global health status, functioning, severity, depression greater patients. Analgesic use also frequent survivors. Breast cancer, being overweight obese, having poorer status identified main factors increasing likelihood pain. therefore remains Further improvements management are needed, strategies target chronic pain, high frequency associated with breast cancer. Multimodal interventions improve help individuals maintain healthy weight, reduce could be evaluated.

Язык: Английский

Relationship between pain and nonopioid substance use in two national samples of cancer survivors DOI Creative Commons
Jessica M. Powers, Lisa R. LaRowe, Dana Rubenstein

и другие.

Cancer, Год журнала: 2025, Номер 131(4)

Опубликована: Фев. 10, 2025

Pain is related to greater odds of cigarette use, e‐cigarette and cannabis use lower likelihood alcohol among cancer survivors in the United States. Current smoking pain are also treatment‐related side effects worse physical/mental health survivors.

Язык: Английский

Процитировано

2
USO DE MEDICAMENTOS PSICOTRÓPICOS NA GRAVIDEZ E LACTAÇÃO: UMA REVISÃO DAS EVIDÊNCIAS ATUAIS SOBRE OS RISCOS E BENEFÍCIOS PARA A SAÚDE MENTAL DA MÃE E DO BEBÊ DOI Creative Commons

Paula Rosalia Kelberman Castronovo,

Carlos Henrique Moulin Naumann, Patrícia Sales Braga

и другие.

International Journal of Health Management Review, Год журнала: 2024, Номер 10(1), С. e348 - e348

Опубликована: Июль 24, 2024

Este trabalho consiste em uma revisão minuciosa das evidências atuais sobre o uso de medicamentos psicotrópicos durante a gravidez e lactação, com intuito avaliar os potenciais riscos benefícios para saúde mental da mãe do bebê. Serão abordados aspectos farmacocinéticos farmacodinâmicos dos principais psicotrópicos, bem como passagem placentária excreção no leite materno. Além disso, serão discutidos impactos desses na gestante, possíveis efeitos adversos neonatais, desenvolvimento cognitivo comportamental longo prazo, as recomendações clínicas práticas, considerações éticas legais relacionadas ao tema. Ao final, apresentados achados implicações prática clínica.

Процитировано

0
Assessment of pain prevalence in cancer patients undergoing anticancer treatments and in cancer survivors after completion of anticancer treatments: A French nationwide cross‐sectional study DOI

Charles Ragusa,

Bruno Pereira, David Balayssac

и другие.

International Journal of Cancer, Год журнала: 2024, Номер unknown

Опубликована: Дек. 3, 2024

Abstract Pain is a common and disabling symptom of cancer its treatment. This study aimed to provide an update on the prevalence, characteristics, impact pain quality life (QoL) in patients survivors France. Data were collected using self‐assessment questionnaires as part nationwide web‐based survey conducted between January March 2023. was reported by 44.7% population ( n = 1029), including 49.2% (95% CI [44.8; 53.6]) 255/518) 40.1% [35.8; 44.5]) 205/511). Chronic more prevalent among (99.0%) than (87%), but no between‐group differences prevalence neuropathic (66.8% vs. 67.5%, respectively) or other characteristics (pain intensity, location, etc.) observed. had negative QoL both groups, global health status, functioning, severity, depression greater patients. Analgesic use also frequent survivors. Breast cancer, being overweight obese, having poorer status identified main factors increasing likelihood pain. therefore remains Further improvements management are needed, strategies target chronic pain, high frequency associated with breast cancer. Multimodal interventions improve help individuals maintain healthy weight, reduce could be evaluated.

Язык: Английский

Процитировано

0